Inogen Q2 revenue up driven by higher demand for portable oxygen concentrators

Inogen

06/08/2026 21:45

Overview
U.S. respiratory device maker's Q2 revenue up 3% yr/yr, slightly missed analyst expectations
Q2 adjusted EBITDA rose 15% and beat analyst expectations
Company raised full-year adjusted EBITDA guidance to $4.0 mln

Outlook
Inogen raises 2026 adjusted EBITDA guidance to about $4.0 mln
Company sees 2026 revenue between $355 mln and $361 mln
Inogen expects Q3 revenue to be roughly in line with Q3 2025

Result Drivers
INTERNATIONAL SALES - Co said Q2 revenue growth was primarily driven by higher demand for portable oxygen concentrators in international markets and favorable foreign exchange rates
U.S. SALES WEAKNESS - U.S. sales and rentals remained below prior-year period, though co said it gained traction with U.S. distributors and expanded product portfolio
GROSS MARGIN IMPROVEMENT - Adjusted gross margin rose due to improvements in cost of revenue

Company press release: ID:nBw7g4dzba

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Slight Miss*
$95.10 mln
$95.23 mln (3 Analysts)
Q2 Loss Per Share
 
$0.14
 
Q2 Net Loss
 
$3.90 mln
 
Q2 Adjusted EBITDA
Beat
$2.40 mln
$1.71 mln (3 Analysts)
Q2 Gross Margin
 
45.50%
 
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Inogen, Inc. is $12.00, about 82.9% above its August 5 closing price of $6.56

Reuters Recommended Reads
Aug 3 - Viemed Healthcare Q2 revenue rises on ventilator patient growth
Aug 4 - AdaptHealth Q2 revenue misses estimates
Aug 5 - United Therapeutics Q2 revenue misses estimates on Ebulized Tyvaso weakness

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)